SCEJ

$B2=3X9)3X2q(B $BBh(B47$B2s=)5(Bg2q(B

$B9V1i%W%m%0%i%`!J2q>l!&F|DxJL!K(B

English page

F $B2q>l(B

$B:G=*99?7F|;~!'(B2015-08-26 10:00:42

$BBh(B 1 $BF|(B
$B9V1i(B
$B;~9o(B		$B9V1i(B
$BHV9f(B		$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BJ,N`(B
$BHV9f(B		$B$BHV9f(B
$BIt2q%7%s%]%8%&%`(B SY-14. <$B8GAj$NIJ=@O5;=Q$K4X$9$k%7%s%]%8%&%`!J:`NA!&3&LLIt2q!K(B>
$B$3$N%7%s%]%8%&%`$N9V1i;~4V$O(B $BH/I=#1#2J,!\F$O@#8J,(B $B$G$9!#(B
(9:00$B!A(B10:40) ($B:BD9(B $BA0ED(B $B8w<#(B)
9:00$B!A(B 9:20F101$B%7%_%e%l!<%7%g%s$K$h$kM-5!J*7k>=$N3K2=!&@.D9B.EY%Q%i%a!<%?;;=P(B
($BAaBgM}9)(B) ($B3X(B)$B!{G_ED(B $BN4B@(B$B!&(B ($B3X(B)$BIJED(B $B>042(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B
nucleation rate
growth rate
simulation
SY-14597
9:20$B!A(B 9:40F102$B?e;@2=%9%H%m%s%A%&%`(B8$B?e1v7k>=$rE:2C$7$?1v2=%+%k%7%&%`(B6$B?e1vM;1U$N2aNd5Q29EY$K5Z$\$9r7o$N1F6A(B
($BAaBgM}9)8&(B) ($B@5(B)$BEOn5(B $BM5G7(B
Nucleation
Melt
Heat Storage
SY-1422
9:40$B!A(B 10:00F103N2$B%U%!%$%s%P%V%k$HIOMOG^$NJ;MQ$K$h$k%0%j%7%s$N>=@O8=>](B -$BIOMOG^$N=B?7A$K5Z$\$91F6A(B-
($BF|Bg@8;:9)(B) ($B3X(B·$B5;4p(B)$B!{A0_7(B $B>MB@(B$B!&(B ($B@5(B)$B:4F#(B $BIR9,(B$B!&(B ($B@5(B)$B2,ED(B $B>;$B!&(B ($B@5(B)$BF|=)(B $B=SI'(B$B!&(B ($B@5(B)$B>>K\(B $B??OB(B
glycine
antisolvent crystallization
fine-bubbles
SY-14869
10:00$B!A(B 10:20F104ASP3026$B$N7k>=B?7A@)8f@oN,$H%$%s%i%$%s%i%^%sJ,8wK!$rMQ$$$?MO1U9=B$%b%K%?%j%s%0(B
($B%"%9%F%i%9@=Lt(B) ($BK!(B)$B!{C]8}(B $BOB9((B$B!&(B ($BK!(B)$B>.]$(B $BOB5A(B$B!&(B ($BK!(B)$BJ?_7(B $B=S(B$B!&(B ($BK!(B)$B?%0f(B $BN<5#(B$B!&(B ($BK!(B)$B2,ED(B $BL-(B$B!&(B ($B%"%9%F%i%9%U%!!<%^%F%C%/(B) ($BK!(B)$B2HED(B $B@.(B$B!&(B ($BG@9)Bg(B) ($B@5(B)$BBl;3(B $BGn;V(B
Polymorph
Raman
SY-1419
10:20$B!A(B 10:40F105$B=E:2C$K$h$k%5%V%_%/%m%s%*!<%@!<$K$*$1$k(BPt$BN3;R$NN37B@)8f(B
($BAaBg(B) ($B3X(B)$B!{0KCNCO(B $B??@!(B$B!&(B ($B3X(B)$B=)MU(B $B9I;R(B$B!&(B ($B3X(B)$BD9Hx(B $B1Q;V(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B
Reaction Crystallization
Size Control
Pt Particle
SY-14712
(10:40$B!A(B12:00) ($B:BD9(B $BA%1[(B $BK.IW(B)
10:40$B!A(B 11:00F106$B4T85>=@O$K$*$1$k(BpH$B$K$h$k(BAu$BN3;R$NN37B@)8f$*$h$SN3;R@.D95!9=$N2rL@(B
($BAaBg1!M}9)(B) ($B3X(B)$B!{=)MU(B $B9I;R(B$B!&(B ($B3X(B)$B0KCNCO(B $B??@!(B$B!&(B ($BAaBgM}9)(B) ($B@5(B)$BJ?Bt(B $B@t(B
reaction crystallization
pH
sub-micron Au particle
SY-14947
11:00$B!A(B 11:20F107$B7Z>F(Bdolomite$B7|By1U$NC:;@2=H?1~$K$h$k(BMg$BC:;@1v$N>=@O$HJ,N%(B
($B85ElKLBg1!4D(B) ($B3X(B)$B2,ED(B $B2BM4(B$B!&(B ($BElKLBg1!4D(B) ($B3X(B)$B!{9b66(B $BCRH~(B$B!&(B ($B@5(B)$BEDCf(B $B9(0l(B$B!&(B ($BElKLBg1!9)(B) ($B@5(B)$BEOn5(B $B8-(B$B!&(B ($BElKLBg1!4D(B) ($B@5(B)$BAjED(B $BBn(B$B!&(B ($B@5(B)$B%9%_%9(B $B%j%A%c!<%I(B
dolomite
carbonation
magnesium carbonate
SY-14786
11:20$B!A(B 11:40F108$BH?1~>=@OK!$K$h$kC:;@1vHy7k>=$NIJ
($BAaBg@h?JM}9)(B) ($B@5(B)$B!{J?Bt(B $B@t(B$B!&(B ($B3X(B)$B@>B<(B $B5f(B$B!&(B ($B3X(B)$B1`It(B $BM4;R(B$B!&(B ($B3X(B)$BLJB<(B $B9@?M(B
$BH?1~>=@O(B
$BC:;@1vHyN3;R(B
$BIJ		SY-14133
11:40$B!A(B 12:00F109$B%I%i%`%U%l!<%+$rMQ$$$?6&>=E`7k>=@OK!$K$h$k(B(NH4)2SO4-Na2SO4-H2O$B7O$+$i$NG;=LN20B1U2s<}$NJ,N%FC@-$=$NB>$K$D$$$F(B
($B%+%D%i%.9)6H(B) ($BK!(B)$B!{5HED(B $BM55,(B$B!&(B ($BK!(B)$BOPED(B $B>09((B$B!&(B ($B@5(B)$B;0LZ(B $B=(M:(B$B!&(B ($BJ<8K8)Bg9)(B) ($B@5(B)$BA0ED(B $B8w<#(B
Drum flaker
Eutectic point
freezing concentration
SY-14433
(13:00$B!A(B14:20) ($B:BD9(B $BEgFb(B $B
13:00$B!A(B 13:20F113$B;iKC;@$NM;1U>=@O$K$*$1$kMO
($BJ<8K8)Bg9)(B) ($B3X(B)$B!{F#@n(B $BBv?M(B$B!&(B ($B@5(B)$B;3K\(B $BBs;J(B$B!&(B ($B@5(B)$BA0ED(B $B8w<#(B$B!&(B ($B@5(B)$BJ!0f(B $B7<2p(B$B!&(B ($B9q4D8&(B) ($B@5(B)$BAR;}(B $B=(IR(B
melt crystallization
effective distribution coefficient
solute distribution theory
SY-14171
13:20$B!A(B 13:40F114Cr($B-7(B)$BB8:_2<$G$NN2;@%+%j%&%`7k>=$NMO2r$K$*$1$k3F7k>=LL$NI=LL2r@O(B
($BNk$B!&(B $B:,4_(B $BN$F`(B
Dissolution Behavior
Additives
Energy Dispersive X-ray Spectrometry
SY-14538
13:40$B!A(B 14:00F115$B9b05NO2<$G$NL5EE2r%K%C%1%k!>%j%s$a$C$-$K4X$9$k
($BJ<8K8)Bg9)(B) ($B3X(B)$B!{?.5H(B $BM5B@(B$B!&(B ($B@5(B)$B;3K\(B $BBs;J(B$B!&(B ($B@5(B)$BA0ED(B $B8w<#(B$B!&(B ($B6&(B)$BJ!<<(B $BD>$B!&(B ($B6&(B)$BH,=E(B $B??<#(B$B!&(B ($B@5(B)$BJ!0f(B $B7<2p(B
electroless plating
high pressure
hydrogen
SY-14172
14:00$B!A(B 14:20F116$B;0;@2=%b%j%V%G%s?eOBJ*E:2C$K$h$k(BZMH$B7k>=$NJILLIUCeM^@)(B
($BAaBgM}9)(B) ($B3X(B)$B!{0KF#(B $BBgM:(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B
Nuclear fuel reprocessing
Zirconium molybdate hydrate
Nucleation
SY-14675
(14:20$B!A(B15:40) ($B:BD9(B $BCfB<(B $B0lJf(B)
14:20$B!A(B 14:40F117$B%*%$%j%s%0%"%&%H$r7PM3$9$k7k>=2=8=>]$NB?@.J,Aj?^$rMQ$$$?2r@O(B
($BG@9)Bg1!9)(B) ($B3X(B)$B!{1|=P(B $BMu(B$B!&(B ($B@5(B)$B9)F#(B $BfF;|(B$B!&(B ($B@5(B)$BBl;3(B $BGn;V(B
Crystallization
Oiling-out phenomena
Phase diagram
SY-14176
14:40$B!A(B 15:00F118$B%*%$%k2=$r2p$7$?%0%k%?%A%*%s%J%H%j%&%`7k>=$N>=@O(B
($B:e;TBg1!9)(B) ($B@5(B)$B!{8^==Mr(B $B9,0l(B$B!&(B $BNkLZ(B $BM:Bg(B$B!&(B ($B6(OBH/9Z%P%$%*(B) ($BIt(B)$BD9Ln(B $B9((B$B!&(B ($B:e;TBg1!9)(B) ($B@5(B)$BBgEh(B $B42(B
crystallization
solvate
amorphous
SY-14582
15:00$B!A(B 15:20F119$B@EEEE*Aj8_:nMQ$r6nF0NO$H$7$?%9%H%l%W%H%"%S%8%s$N7k>=2=(B
($BElBg1!9)(B) ($B@5(B)$B!{FnH*(B $B9'2p(B$B!&(B ($B3X(B)$B;0IJ(B $B6)1{(B$B!&(B ($B86;RNO5!9=!&NL;R%S!<%`(B) $B0BC#(B $B4pBY(B$B!&(B $B@6?e(B $BN\H~(B$B!&(B $B9uLZ(B $BNIB@(B$B!&(B ($BElBg1!9)(B) ($B@5(B)$BD9Eo(B $B519T(B
Electrostatic interaction
Crystallization
Streptavidin
SY-14512
15:20$B!A(B 15:40F120$B0[Aj3&LL$r>=@O>l$H$7$?7k>=N3;R72$N@.D98=>]$N4Q;!$H$=$NI>2A(B
($BG@9)Bg1!9)(B) ($B3X(B)$B!{NkLZ(B $B=U9a(B$B!&(B ($B@5(B)$B9)F#(B $BfF;|(B$B!&(B ($B@5(B)$BBl;3(B $BGn;V(B
Crystallization
Templated crystallization
Different Phase Interface
SY-14178
(15:40$B!A(B17:20) ($B:BD9(B $B8^==Mr(B $B9,0l(B)
15:40$B!A(B 16:00F121$B%"%_%m%$%I@-%?%s%Q%/
($B2,;3Bg1!4D@8(B) ($B@5(B)$B!{EgFb(B $B$B!&(B ($B3X(B)$B4dB<(B $BH~$B!&(B ($B@5(B)$BLZB<(B $B9,7I(B
Amyloid
Nucleation
Bio-interface
SY-14933
16:00$B!A(B 16:20F122$BDKIw$K$*$1$kG";@@O=P$KM?$($k29EY$N1F6A(B
($BAaBgM}9)(B) ($B3X(B·$B5;4p(B)$B!{Bg;3(B $BGn;K(B$B!&(B ($B@5(B)$B>.KY(B $B?<(B$B!&(B ($B@5(B)$BJ?Bt(B $B@t(B
crystallization
uric acid
gout
SY-14813
16:20$B!A(B 16:40F123$B5U?;F)Kl$K$h$kMO=@8@.(B
($B2#9qBg9)(B) ($B@5(B)$B!{CfB<(B $B0lJf(B$B!&(B $BIz8+(B $B$"$:$5(B
Reverse Osmosis
Crystallization
Concentration Polarization
SY-14558
16:40$B!A(B 17:00F124$B%7%/%m%G%-%9%H%j%s7O6bB0M-5!9=B$BN$X$NK'9aB2%+%k%\%s;@$N5[Ce(B
($B?rBg9)(B) ($B3X(B)$B!{F;ED(B $B9R(B$B!&(B ($B3X(B)$B1J0f(B $B0IF`(B$B!&(B ($B@5(B)$B]/LZ(B $BH~:Z(B$B!&(B ($B@5(B)$B@>ED(B $B@5;V(B$B!&(B ($B@5(B)$BApJI(B $B9n8J(B
Adsorption
Carboxylic acid
Cyclodextrin
SY-14116
17:00$B!A(B 17:20F125$B%(%T%,%m%+%F%-%s%,%l!<%H$N%7%/%m%G%-%9%H%j%sJq@\2=9gJ*$N7k>=@.D9B.EY$N2r@O(B
($BJ!;3Bg@8L?9)(B) ($B@5(B)$B;3K\(B $B1QFs(B$B!&(B ($B@5(B)$B!{Cf:j(B $B@i?R(B$B!&(B ($BJ!;3BgLt(B) $BC]ED(B $B:;5-(B$B!&(B ($BJ!;3Bg@8L?9)(B) $B|bED(B $BM}$B!&(B $B2<;J(B $BBg5.(B
Clathrate
Crystallization
Cyclodextrin
SY-14781

$BBh(B 2 $BF|(B
$B9V1i(B
$B;~9o(B		$B9V1i(B
$BHV9f(B		$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BJ,N`(B
$BHV9f(B		$B$BHV9f(B
$BIt2q%;%C%7%g%s(B SE-3. <$B%a%G%#%+%k$H2=3X9)3X(B>
(9:00$B!A(B10:20) ($B:BD9(B $B?y1:(B $B?5<#(B)
9:00$B!A(B 9:20F201$B4VMU7O44:YK&IuF~%O%$%I%m%2%k$rMQ$$$?J"KlL~CeKI;_8z2L$N8!F$(B
($BElBg0e(B) ($B3X(B)$B@>;3(B $BE0(B$B!&(B ($B3X(B)$B@L(B $Bj6(B$B!&(B ($B@5(B)$BB@ED(B $B@?0l(B$B!&(B $B@6?e(B $BFF;V(B$B!&(B $B0p3@(B $BE_$B!&(B $BD9C+@n(B $B7i(B$B!&(B $BT"EZ(B $BE59((B$B!&(B ($B@5(B)$B!{0KF#(B $BBgCN(B
mesenchymal stem cell
peritoneal adhesion
hydrogel
SE-352
9:20$B!A(B 9:40F202$B%Z%W%A%I%"%W%?%^!<$K$h$k(BCNT$B%;%s%5%G%P%$%9$X$N8w2=3X7O(BI$BJ#9gBN$NG[8~=$>~(B
($BElM}Bg9)(B) ($B@5(B)$B!{EhED(B $BM'0lO:(B$B!&(B ($BElM}Bg1!(B) $BFs0f(B $BBgJe(B$B!&(B $B:Y@n(B $B0+(B$B!&(B ($BElM}Bg9)(B) ($B@5(B)$BG;OB(B$B!&(B ($B@5(B)$B>1Ln(B $B8|(B$B!&(B ($B@5(B)$BBgC](B $B>!?M(B$B!&(B ($BElM}BgM}(B) $Bp](B $BC#Li(B
peptide aptamer
carbon nanotube thin-film transistor
photosystem
SE-3734
9:40$B!A(B 10:00F203$B<+8J=89gBN$NA*BrE*$JD4@=$H9=B$FC0[E*$JFC@-$NI>2A(B
($BF`NI9b@lJ*$B!&(B $BHW0f(B $B=(9a(B$B!&(B $B2CF#(B $B0=;R(B$B!&(B ($B@5(B)$BCfB<(B $B=(H~(B
Self-assembly
Drug delivery
Vesicle
SE-3646
10:00$B!A(B 10:20F204$BEE;R%a%G%#%(!<%?!<$rFbJq$7$?J,;R%$%s%W%j%s%H9bJ,;R8GDjEE6K$K$h$k%P%s%3%^%$%7%s$N%j%(!<%8%'%s%H%l%9%;%s%7%s%0(B
($B$B!&(B ($B3X(B)$BBgJ?(B $B9@;K(B
ferrocene
vancomycin
molecularly imprinted polymer
SE-3963
(10:40$B!A(B12:00) ($B:BD9(B $B5H8+(B $BLwCK(B)
10:40$B!A(B 11:00F2063$Bu$K$h$k$,$s:YK&A*H4%7%9%F%`$N3+H/(B
($B;:Am8&AOLt4pHW(B) $BEDB<(B $BKa@;(B$B!&(B ($BL>Bg1!AOLt2J3X(B) $B=BED(B $B??7k(B$B!&(B ($B;:Am8&AOLt4pHW(B) ($B@5(B)$B?y1:(B $B?5<#(B$B!&(B $B9bLZ(B $B=SG7(B$B!&(B $B?\4](B $B8xM:(B$B!&(B ($BC^GHBg>C2=4oFb2J(B) $B>>0f(B $BM5;K(B$B!&(B ($B%(%s%8%K%"%j%s%0%7%9%F%`(B) $BLxBt(B $B??@!(B$B!&(B ($BL>Bg1!AOLt2J3X(B) ($B@5(B)$B3*9>(B $B7E(B$B!&(B ($B@5(B)$B2CF#(B $BN5;J(B$B!&(B ($B;:Am8&AOLt4pHW(B) ($B@5(B)$B!{6b?9(B $BIR9,(B
imaging cytometry
3D cell culture
photodegradable hydrogel
SE-3587
11:00$B!A(B 11:20F207iPS$B:YK&$N$+$sN.G]M\$K4X$9$k?tCM%7%_%e%l!<%7%g%s(B
($B:eBg1!4p9)(B) ($B3X(B)$B!{NkLZ(B $B42;R(B$B!&(B ($B3X(B)$B;3K\(B $BBnLi(B$B!&(B ($B@5(B)$B9bLZ(B $BMNJ?(B$B!&(B ($B@5(B)$B2,Ln(B $BBYB'(B$B!&(B ($B;:Am8&(B) ($B@5(B)$B?y1:(B $B?5<#(B$B!&(B $B?\4](B $B8xM:(B$B!&(B ($B@5(B)$B6b?9(B $BIR9,(B$B!&(B ($B:eBg1!9)(B) ($B@5(B)$B5*%N2,(B $B@5Gn(B
iPS cells
perfusion culture
numerical simulation
SE-3237
11:20$B!A(B 11:40F208Open Sandwich ELISA$BK!$K$h$k;@2=%9%H%l%9%^!<%+!<;i
($BEl9)Bg;q8;8&(B) ($B@5(B)$B!{F!(B $B6b2Z(B$B!&(B ($B;:Am8&7r9/9)3X(B) $B<7N$(B $B85FD(B$B!&(B ($BL>Bg1!@8L?G@3X(B) $B$B!&(B $BFbED(B $B9@Fs(B$B!&(B ($B;:Am8&7r9/9)3X(B) $B5HED(B $B9/0l(B$B!&(B $BGk86(B $B5A5W(B$B!&(B ($BEl9)Bg;q8;8&(B) ($B@5(B)$B>eED(B $B9((B
$B93BN(B
$BLH1VB,Dj(B
$B;@2=;i		SE-3760
11:40$B!A(B 12:00F209Influence of particle size on demineralization behavior of bovine bone granules
($B?73cBg<+(B) Wei Tingting$B!&(B ($BF;Am8&(B) ($B@5(B)$B@V_7(B $BIRG7(B$B!&(B ($BKL0eBg;u(B) $BB!(B$B!&(B ($B?73cBg9)(B) ($B@5(B)$B!{LZB<(B $BM&M:(B
particle size
bovine bone
demineralization
SE-3220
(13:00$B!A(B14:20) ($B:BD9(B $B0KF#(B $BBgCN(B)
13:00$B!A(B 13:40F213[$B>7BT9V1i(B] $B0eNE5!4o3+H/$H9bJ,;R:`NA(B
($B%F%k%b(B) $B@iLn(B $BD>9'(B
Medical device
Polymer
SE-3610
13:40$B!A(B 14:00F215$B7lE|CM@)8f$rL\;X$7$?%0%k%3!<%96nF0<0$NLtJ*J|=P%7%9%F%`(B($B?M9)$9$$B!(B)$B$K4X$9$k8&5f(B
($BEl0e;uBg(B) ($B3X(B)$B!{$B!&(B $B%`%s%U%8%c%k%,%k(B $B%`%s%U%P%d%k(B$B!&(B $B7*86(B $B9/;J(B$B!&(B $BaDKc(B $B9@;J(B$B!&(B $B9S@n(B $B5.Gn(B$B!&(B $B;0NS(B $B9@Fs(B
Chemo-mechanic energy conversion
enzymes
Drug release system
SE-3624
14:00$B!A(B 14:20F216$BJ,;R%$%s%W%j%s%H9bJ,;R8GDjEE6K$K$h$k0BDj$7$?A47lCf%X%Q%j%sG;EY%;%s%7%s%0(B
($B$B!&(B $B0pMU(B $BNI(B$B!&(B $B>.@n(B $B5.Li(B$B!&(B ($B@t9)0e2J(B) $B0f>e(B $B>-(B$B!&(B $B7,L>(B $B9nG7(B
heparin
surface treatment
molecularly imprinted polymer
SE-3964
(14:20$B!A(B15:00) ($B;J2q(B $B?y;3(B $B90OB(B)
14:20$B!A(B 15:00F217[$B>7BT9V1i(B] $B0eLtIJ@=B$%W%m%;%9$N@_7W!&4IM}!&2~A1$K$*$1$k2=3X9)3X$NLr3d(B
($B1vLn5A@=Lt(B) $B5H@n(B $B3P(B
Pharmaceutical manufacturing
SQDC
industrial case study
SE-3893
(15:00$B!A(B16:00) ($B:BD9(B $BGO>l(B $B0l2E(B)
15:00$B!A(B 15:20F219$B9bLtM}3h@-0eLtIJ;\@_$NLt?PIu$89~$aI>2AJ}K!$K4X$9$k8!F$(B
($B@6?e7z@_(B) ($B@5(B)$B!{EDCf(B $B7.(B$B!&(B ($BK!(B)$B0$It(B $B8x4x(B$B!&(B ($BK!(B)$B;3ED(B $BMF;R(B$B!&(B ($BK!(B)$B:dK\(B $BDw;V(B$B!&(B ($BK!(B)$B?\2l(B $B9/G7(B
high potent pharmaceutical compound
containment
monitoring
SE-3112
15:20$B!A(B 15:40F220JIT$B7?%b%G%k$rMQ$$$?@=LtB$N39)Dx:GE,2=(B
($B5~Bg>pJs(B) $B5H:j(B $BN<2p(B$B!&(B ($B@5(B)$B!{2CG<(B $B3X(B$B!&(B ($BBh0l;06&(B) $BEDn5(B $B=$0l(B$B!&(B $B5\Ln(B $BBsLi(B
pharmaceutical granulation process
locally weighted partial least squares
self-adaptive differential evolution
SE-39
15:40$B!A(B 16:00F221$B0eLtIJ@=B$%W%m%;%9$N@_7W;Y1g%D!<%k$H$7$F$N%W%m%;%9%7%9%F%`9)3X(B
($BElBg1!9)(B) ($B@5(B)$B?y;3(B $B90OB(B
Pharmaceutical manufacturing
Process design
Single use
SE-3181
$BIt2q%;%C%7%g%s(B SE-2. <$B:F@80eNE$K$*$1$k2=3X9)3XE*%"%W%m!<%A(B>
(16:20$B!A(B17:00) ($B:BD9(B $BCf_7(B $B9@Fs(B)
16:20$B!A(B 16:40F223$B%P%$%*?M9)4NB!$N4pHW5;=Q$H$7$F$N0dEA;RF3F~%^%&%9%X%Q%H!<%^:YK&$NCf6u;eG]M\(B
($B6eBg1!9)(B) ($B@5(B)$B!{?eK\(B $BGn(B$B!&(B ($B6eBg1!%7%9@8(B) ($B3X(B)$BF#0f(B $BM4Je(B$B!&(B ($B6eBg1!9)(B) ($B@5(B)$B>eJ?(B $B@5F;(B$B!&(B ($B@5(B)$B3a86(B $BL->0(B
artificial liver
hollow fiber
hepatoma cell
SE-2553
16:40$B!A(B 17:00F224$BB!4o9)3XE*4NB!9=C[$K8~$1$?7l1U=[4DG]M\7O$N3+H/(B
($B6eBg1!9)(B) ($B@5(B)$B!{0fEh(B $BGnG7(B$B!&(B ($B3X(B)$B:dK\(B $BM54u(B$B!&(B $Bld(B $B:KMG(B$B!&(B ($B@5(B)$BGrLZ@n(B $BF`:Z(B$B!&(B ($B6eBg1!0e(B) $B:#0f(B $BBgM4(B$B!&(B ($B6e=#$,$s%;(B) $B;32<(B $BMN;T(B$B!&(B ($B6eBgFs30(B) $BD4(B $B7{(B$B!&(B $BA086(B $B4nI'(B
Whole Organ Engineering
Liver
Ammonia metabolism
SE-2414

$BBh(B 3 $BF|(B
$B9V1i(B
$B;~9o(B		$B9V1i(B
$BHV9f(B		$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BJ,N`(B
$BHV9f(B		$B$BHV9f(B
$BIt2q%;%C%7%g%s(B SE-2. <$B:F@80eNE$K$*$1$k2=3X9)3XE*%"%W%m!<%A(B>
(9:00$B!A(B10:20) ($B:BD9(B $B0fEh(B $BGnG7!&?eK\(B $BGn(B)
9:00$B!A(B 9:20F301$B%^%$%/%m%&%'%kG]M\$rMQ$$$?%^%&%9(BiPS$BfuMMBNJ,2=FC@-$N@)8f(B
($BKL6eBg1!9)(B) ($B3X(B)$B!{5\K\(B $BBgJe(B$B!&(B ($B3X(B)$B;38}(B $B7rB@(B$B!&(B ($B@5(B)$BCf_7(B $B9@Fs(B
microwell culture
mouse iPS cells
Embryoid body
SE-2186
9:20$B!A(B 9:40F302$B4VMU7O44:YK&A}?#MQ$N%^%$%/%m%-%c%j%"$H3IYB>r7o$N8!F$(B
($BKLBg9)(B) $B9b66(B $B0K?%(B$B!&(B $B:4F#(B $B7<8g(B$B!&(B ($BIp8K=wBg!&7r%9%](B) $BL\NI(B $B91(B$B!&(B ($B9-Bg0e(B) $BOFC+(B $B<"G7(B$B!&(B ($BKLBg9)(B) ($B@5(B)$B!{9bLZ(B $BKS(B
Mesenchymal stem cell
microcarrier
agitation
SE-227
9:40$B!A(B 10:00F303$B:YK&NEK!$X8~$1$?%7%s%0%k%f!<%95;=Q$rMQ$$$?@8;:%W%i%C%H%U%)!<%`(B
($B%a%k%/(B) ($B@5(B)$B!{IY2,(B $BM%2p(B$B!&(B (EMD Millipore) Schnitzler A.$B!&(B Rigby S.$B!&(B Kehoe D.$B!&(B Aysola M.$B!&(B Punreddy S.$B!&(B Verma A.$B!&(B Lawson T.$B!&(B Murrell J.$B!&(B Rook M.$B!&(B ($B%a%k%/(B) ($B@5(B)$B0KF#(B $BN4IW(B
Stem Cell
Cell Therapies
single use
SE-2151
10:00$B!A(B 10:20F304$B%-%a%i
($BElBg1!9)(B) ($B@5(B)$B!{2O86(B $B@59@(B$B!&(B ($B3X(B)$BCfNS(B $B=(?M(B$B!&(B $B@D;3(B $B9,7C;R(B$B!&(B ($B3X(B)$BD@(B $B>bA?;R(B$B!&(B ($B@5(B)$BD9Eo(B $B519T(B
chimeric receptor
cell differentiation
cost reduction
SE-2305
(10:40$B!A(B11:20) ($B;J2q(B $B:j;3(B $BN<0l(B)
10:40$B!A(B 11:20F306[$B>7BT9V1i(B] $B:F@80eNE$K$*$1$k:YK&$NIJ
($B%5!<%b%U%#%C%7%c!<%5%$%(%s%F%#%U%#%C%/(B) ($B@5(B)$B_'C+(B $BL@9((B
BioProduction
Cell Therapy
Pharma Analytics
SE-2250
(11:20$B!A(B12:00) ($B:BD9(B $BJ!ED(B $B=_Fs(B)
11:20$B!A(B 11:40F308$BD62;GHI=LL=$>~K!$K$h$k%;%U%!%>%j%s=yJ|@-%"%Q%?%$%HJ#9gpyN3$N5!G=@_7W$HFC@-I>2A(B
($BF;Am8&(B) ($B@5(B)$B!{@V_7(B $BIRG7(B$B!&(B $BLnB<(B $BN4J8(B$B!&(B ($BKL0eBg(B) $BB!(B$B!&(B $BFnED(B $B9/?M(B$B!&(B ($BKL3$F;0eNE%;(B) $B0KEl(B $B3X(B$B!&(B (HOYA Technosurgical) $BCfEg(B $BIpI'(B$B!&(B $B:dK\(B $BH~CN;R(B
Hydroxyapatite Composite Granules
Cefazolin-Release Characteristics
Supersonic Surface Modification
SE-2271
11:40$B!A(B 12:00F309$BJ"Kl%b%G%k$N:n@=$HJ"Kl=}320x;R$K$h$kMO2A(B
($BEl=w0eBgNW9)(B) ($B@5(B)$B!{:j;3(B $BN<0l(B$B!&(B ($BK!@/Bg1!M}9)(B) ($B3X(B)$BBgFb(B $BTw(B$B!&(B ($BK!@/Bg@8L?(B) ($B@5(B)$B;32<(B $BL@BY(B$B!&(B ($BEl=w0eBg@hC<@8L?0e2J3X8&(B) $BBgOB(B $B2mG7(B$B!&(B ($BEl=w0eBgNW9)(B) ($B@5(B)$BJvEg(B $B;0@iCK(B
peritoneal model
cell sheet
SE-2385
$B9V1iH/I=%W%m%0%i%`(B
$B2=3X9)3X2q(B $BBh(B47$B2s=)5(Bg2q(B
(C) 2015 $B8x1W
Most recent update: 2015-08-26 10:00:42
For more information contact $B2=3X9)3X2qK\ItBg2q1?1D0Q0w2q(B $BBh(B47$B2s=)5(Bg2q(B $BLd$$9g$;78(B
E-mail: inquiry-47fwww3.scej.org
This page was generated by easp 2.38; proghtml 2.37 (C)1999-2015 kawase